RU-SKI 43 - Hhat Inhibitor. CAS# 1043797-53-0 60077 BG45 alone and in combination

BG45 alone and in combination with bortezomib triggers significant tumor growth inhibition in vivo in a murine xenograft model of human MM

Solubility: DMSO: ≥ 45 mg/mL

and DNA-PK

CUDC-907 was orally dosed to mice at 100 mg/kg or intravenously dosed at 50 mg/kg once per day in the xenograft tumor model of SU-DHL4 (DLBCL) and A549 (NSCLC)

InChiKey: QEKGSBZKRLHQSZ-VSIGASKDSA-N

RU-SKI 43 - Hhat Inhibitor. CAS# 1043797-53-0 60077 BG45 alone and in combinationRU SKI, CAS No. 1043797 53 0, 43 is the first potent and specific small molecule inhibitor of Hedgehog acyltransferase (Hhat), and directly inhibits palmitoylation of the Shh ligand. It was discovered by a high throughput screen using a peptide based assay to monitor Hhat mediated Shh palmitoylation (IC50 ~0. 85 M) . In vitro using purified Hhat and ShhN to analyze the kinetics of compounds inhibition of ShhN palmitoylation, RU SKI 43 behaved as an